←Back to Expert Scholars
Translational Medicine / 转化医学MDS, CH to Leukemia Progression
Benjamin Ebert
MD, PhD
🏢Dana-Farber Cancer Institute🌐USA
Chair of Medical Oncology
115
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Benjamin Ebert has made seminal contributions to MDS biology and uncovered mechanisms linking clonal hematopoiesis to therapy-related myeloid neoplasms. His work also elucidated the molecular mechanism of lenalidomide in del(5q) MDS via CRBN-mediated degradation.
Share:
🧪Research Fields 研究领域
MDS biology
CHIP progression
lenalidomide del5q
therapy-related MDS
molecular degraders
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Benjamin Ebert 的研究动态
Follow Benjamin Ebert's research updates
留下邮箱，当我们发布与 Benjamin Ebert（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment